Medication to lose weight
This page has been reviewed by
Dr. Nicolette Lammers.
Medication for weight reduction
The medications listed below are part of the medical weight loss programs and are offered exclusively as part of the treatments. All medications are available on prescription only. If you are eligible for treatment, the medication will be prescribed by our medical team and shipped by our partner pharmacy on request.

Saxenda
Saxenda is an injectable medicine developed to help adults with obesity lose and maintain their weight. The drug was developed by the pharmaceutical company Novo Nordisk and is only available on prescription.
Administration | Daily injection pen |
Active ingredient | Liraglutide |
Target group | Overweight: BMI ≥30 or BMI ≥27 with a weight-related illness |
Mode of action | The drug is similar to the natural GLP-1 hormone. It regulates the appetite, increases the feeling of satiety and improves the sugar metabolism. |
Side effects |
The most common side effects are nausea, vomiting, diarrhea, constipation, headaches and fatigue.
Side effects Saxenda |
Package insert |
Download the Saxenda package leaflet
Saxenda package leaflet |
Price |
The medication is not available individually, but only as part of the "Lose weight with injections" program. Starter month (low dosage):
|

Ozempic
Ozempic is an injectable medication used to treat type 2 diabetes. It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists. These act on the body’s natural GLP-1 receptors to regulate blood glucose levels.
Administration | Weekly injection pen |
Active ingredient | Semaglutide |
Target group | Type 2 diabetes |
Mode of action | The drug is similar to the natural GLP-1 hormone. It regulates the appetite, increases the feeling of satiety and improves the sugar metabolism. |
Side effects |
The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue.
Ozempic side effects |
Package insert |
Download the Ozempic package leaflet
Ozempic package leaflet |
Price | Prices for the treatment of obesity or overweight with the active ingredient semaglutide can be found below under 'Wegovy'. |

Wegovy
Administration | Weekly injection pen |
Active ingredient | Semaglutide |
Target group | Overweight: BMI ≥30 or BMI ≥27 with a weight-related illness |
Mode of action | The drug is similar to the natural GLP-1 hormone. It regulates the appetite, increases the feeling of satiety and improves the sugar metabolism. |
Side effects |
The most common side effects are headaches, nausea, diarrhea, constipation, vomiting and fatigue.
Wegovy side effects |
Package insert |
Download the Wegovy package leaflet
Wegovy package leaflet |
Price |
The medications are not available individually, but only as part of the program "Losing weight with injections". Starter month (low dosage):
|
Mounjaro
Mounjaro contains the active ingredient tirzepatide and is used to treat type 2 diabetes and for weight control. Mounjaro influences the feeling of hunger and satiety. It lowers blood sugar levels and improves insulin production in the body. The drug also has positive effects on weight loss.
Administration | Weekly injection pen |
Active ingredient | Tirzepatide |
Target group | Type 2 diabetes & overweight: BMI ≥30 or BMI ≥27 with a weight-related illness |
Mode of action | Tirzepatide activates GIP and GLP-1 receptors. This leads to increased insulin release, reduced glucagon secretion, slows gastric emptying and reduces appetite. |
Side effects |
The most common side effects are headache, nausea, diarrhea, constipation, vomiting and fatigue.
Side effects Mounjaro |
Package insert |
Download the Mounjaro package leaflet
Mounjaro package leaflet |
Price |
The medications are not available individually, but only as part of the program "Losing weight with injections". Starter month (low dosage):
|
Rybelsus
Rybelsus is a drug that is used to treat type 2 diabetes. Rybelsus stimulates insulin production and reduces the amount of glucose produced by the liver. This helps to keep blood sugar levels in a healthy range and can reduce risk factors for diabetes such as heart disease, strokes and kidney damage.
Administration | Tablet form, once daily |
Active ingredient | Semaglutide |
Target group | Type 2 diabetes |
Mode of action | The drug is similar to the natural GLP-1 hormone. It regulates appetite and increases the feeling of satiety. |
Side effects |
The most common side effects are hypoglycemia, headache, nausea, diarrhea, constipation, vomiting and fatigue.
Rybelsus side effects |
Package insert |
Download the Rybelsus package leaflet.
Rybelsus package leaflet |
Price | Rybelsus, i.e. the brand name for the oral dosage form of semaglutide, is currently not marketed in Germany. |
Mysimba
Administration | Tablet form, 2x daily |
Active ingredient | Naltrexone / bupropion |
Target group | Overweight: BMI ≥30 or BMI ≥27 with a weight-related illness |
Mode of action | The drug acts on the body's craving system and prevents impulsive eating. |
Side effects |
The most common side effects are dizziness, headaches, palpitations, tiredness and insomnia.
Side effects of Mysimba |
Package insert |
Download the Mysimba package leaflet.
Mysimba package leaflet |
Price | Even if Mysimba is not on the market in Germany, it can be prescribed, imported and dispensed via individual import. Please contact us for price information. |